Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Intima Bioscience

Main focus: Next generation cell therapies for solid tumours

Company stage: Clinical

Diseases: Multiple solid tumours

Genome editing tool: CRISPR-Cas9

Funding stage: Private

Location: New York, USA


Intima Bioscience is a clinical-stage gene and cell therapy company focused on developing cures for solid cancers. The company develops tumour-infiltrating lymphocytes (TILs) in which the novel cytokine checkpoint CISH is disrupted using CRISPR. The company is currently testing its lead programme in multiple solid tumours in a Phase 1/2 clinical trial.


HashtagIntima Bioscience, Inc.

Company: Intima Bioscience
Search CRISPR Medicine